Healthy Extracts Inc. (HYEX) Stock Price & Analysis
Healthy Extracts Inc. (HYEX) — price $1.35 (0.00%), as of the Nov 18, 2026 trading session; market cap $19.9M.
Educational signal · not a buy or sell recommendation · How to read this
Healthy Extracts Inc. · HYEX
Healthy Extracts Inc. focuses on developing and distributing plant-based nutraceuticals targeting heart, brain, and immune health. The company operates through its Corporate and Health Supplements segments, marketing patented products primarily in the United States.
Price as of Nov 18, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $1.35 | |
| Change on the day | 0.00% | |
| 52-week range | $0.8209 – $2.70 | |
| Market capitalisation | $19.9M | |
| Shares traded on the day | 4 |
Price & events
Other perspectives
Council score for Healthy Extracts (HYEX): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 7, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 1, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 1, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Healthy Extracts (HYEX), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Healthy Extracts Inc. (HYEX) is the company analyzed here. It employs 22 people and is led by Donald Swanson. In Q2 FY2026 it reported revenue of $2M and net income of -$129,389. The market values it at $19.9M.
What do the latest results show for Healthy Extracts (HYEX)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $2M.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $2M | -$129,389 | -$0.01 (diluted) |
| Q1 FY2026 | $2M | -$200,590 | -$0.01 (diluted) |
| Q4 FY2025 | $2M | -$153,985 | -$0.01 (diluted) |
| Q3 FY2025 | $917,975 | -$395,394 | -$0.13 (diluted) |
What are the financial strengths and risks for Healthy Extracts (HYEX)?
Short answer · as of
The distress and quality screens read Altman Z -0.17 · Piotroski F 3. Trailing ratios: ROE -3.7% · ROA -2.7% · current ratio 0.20 · earnings yield -4.0% · free-cash-flow yield 2.5%.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of -0.17 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-3.7%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held HYEX in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported HYEX in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Investor Questions: HYEX Stock
These answers are editorial: 2 of these 8 answers are drawn from the HYEX research dossier (written Mar 16, 2026 by gemini-2.0-flash); the other 6 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is HYEX a good stock to buy?
Stock Expert AI does not rate HYEX buy, sell or hold. Healthy Extracts Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the HYEX stock price today?
The last price recorded for Healthy Extracts Inc. (HYEX), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does Healthy Extracts Inc. do?
Healthy Extracts Inc. is a nutraceutical company that develops, patents, markets, and distributes plant-based supplements. It operates in two segments: Corporate and Health Supplements. The company's products target key health areas such as heart, brain, and immune health.
How does Healthy Extracts Inc. navigate regulatory approval processes?
As a nutraceutical company, Healthy Extracts Inc. is subject to regulations from the Food and Drug Administration (FDA) regarding the safety and labeling of its products.
What are the key factors to evaluate for HYEX?
Evaluate HYEX on fundamentals, analyst consensus, and risk factors. This strategy can reduce reliance on direct-to-consumer sales and build a stronger market presence. Not financial advice.
How frequently does HYEX data refresh on this page?
HYEX's price is the last quote we recorded, from the Nov 18, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven HYEX's recent stock price performance?
Healthy Extracts Inc. (HYEX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary and patented products. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HYEX overvalued or undervalued right now?
Healthy Extracts Inc. (HYEX) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 8 from Financial Modeling Prep (FMP) and 5 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com